References
1. Watson RS, Carcillo JA, Walter T, et al: The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 167:695–701
2. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588 –595
3. Mullner M, Urbanek B, Havel C, et al: Vasopressors for shock. Cochrane Database Syst Rev 2004; CD003709
4. Farand P, Hamel M, Lauzier F, et al: Review article: Organ perfusion/ permeability-related effects of norepinephrine and vasopressin in sepsis. Can J Anesth 2006; 53:934 –946
5. McNamara PJ: Too much of a good thing?
6. Oliver GS, Schäfer EA: On the physiological action of extracts of pituitary body and certain other glandular organs. J Physiol (Lond) 1895; 18:277–279
7. Carcillo JA, Fields AI: Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002; 30:1365–1378
8. Mutlu GM, Factor P: Role of vasopressin in the management of septic shock. Intensive Care Med 2004; 30:1276 –1291
9. Russell JA: Vasopressin in vasodilatory and septic shock. Curr Opin Crit Care 2007; 13: 383–391
10. Velden RVD: Die Nierenwirkung con Hypophysenextrakten beim Menschen. Berl Klin Wochenschr 1913; 50:2083–2086
11. Du Vigneaud V, Gish DT, Katsoyannis P: A synthetic preparation possessing biological properties associated with arginine-vasopressin. J Am Chem Soc 1954; 76:4751– 4752
12. Treshcan TA, Peters J: The vasopressin system: Physiology and clinical strategies. Anesthesiology 2006; 105:599 – 612
13. Holmes CL, Landry DW, Granton JT: Science review: Vasopressin and the cardiovascular system part 1—Receptor physiology. Crit Care 2003; 7:427– 434
14. Forrest P: Vasopressin and Shock. Anaesth Intensive Care 2001; 29:463– 472
15. Dünser MW, Wenzel V, Mayr AJ, et al: Management of vasodilatory shock: Defining the role of arginine vasopressin. Drugs 2003; 63: 237–256
16. Shrier R, Berl T, Anderson R: Osmotic and nonosmotic control of vasopressin release. Am J Physiol 1979; 236:F321–F332
17. Oliver JA, Landry DW: Endogenous and exogenous vasopressin in shock. Curr Opin Crit Care 2007; 13:376 –382
18. Hirsch A, Majzoub J, Ren C, et al: Contribution of vasopressin to blood pressure regulation during hypovolemic hypotension in humans. J Appl Phyisiol 1993; 75:1984 –1988
19. Kasting N, Mazurek M, Martin J: Endotoxin increases vasopressin release independently of known physiological stimuli. Am J Physiol 1985; 248:E420 –E424
20. Chikanza I, Petrou P, Chrousos G: Perturbations of arginine vasopressin secretion during inflammatory stress: Pathophysiologic implications. Ann NY Acad Sci 2000; 917: 825– 834
DOI: https://dx.doi.org/10.18535/jmscr/v5i2.166
